MASP2 and hepatic veno-occlusive disease: Inhibition of MASP-2 may provide therapeutic benefits for TA-TMA and potentially other endothelial injury syndromes, including veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)and GVHD.